Quince Therapeutics (QNCX) Shares Issued (2018 - 2026)

Quince Therapeutics (QNCX) posted quarterly Shares Issued of $1.3 million for Q1 2026, up 7800.48% quarter-over-quarter from $16155.0 in Q4 2025.

Quince Therapeutics (QNCX) Shares Issued (2018 - 2026) Analysis & Trends

Quince Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

In Q1 2026, Shares Issued changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $16155.0, down 99.78% from the prior year.
Shares Issued for Q1 2026 stood at $1.3 million, up from $16155.0 in the prior quarter.
The five-year high for Shares Issued was $7.4 million in Q4 2024, with the low at $16155.0 in Q4 2025.
The 5-year median for Shares Issued is $2.1 million (2023), against an average of $2.5 million.
The sharpest annual moves came in 2022 and 2025: Shares Issued soared 821.98% in 2022, then sank 99.78% in 2025.
Quince Therapeutics' Shares Issued stood at $3.7 million in 2022, then tumbled by 37.65% to $2.3 million in 2023, then surged by 217.49% to $7.4 million in 2024, then tumbled by 99.78% to $16155.0 in 2025, then jumped by 7800.48% to $1.3 million in 2026.
Business Quant data shows QNCX's Shares Issued at $1.3 million in Q1 2026, $16155.0 in Q4 2025, and $125034.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Quince Therapeutics	203.43 Mn	203.43 Mn	-	1.19 Mn

Download Data